Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis
- PMID: 17923720
- PMCID: PMC2018774
- DOI: 10.1136/bmj.39350.500428.47
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis
Abstract
Objective: To evaluate the effectiveness of dietary antioxidants in the primary prevention of age related macular degeneration (AMD).
Design: Systematic review and meta-analysis.
Data sources: Search of seven databases without limits on year or language of publication, and retrieval of references in pertinent reviews and articles.
Methods: Two reviewers independently searched the databases and selected the studies, using standardised criteria. Randomised clinical trials and prospective cohort studies were included. Of the 4192 abstracts initially identified, 12 studies (nine prospective cohort studies and three randomised clinical trials) met the selection criteria and were included. Data extraction and study quality evaluation were independently reviewed, using standardised criteria. Results were pooled quantitatively using meta-analytic methods.
Results: The nine prospective cohort studies included 149 203 people, with 1878 incident cases of early AMD. The antioxidants investigated differed across studies, and not all studies contributed to the meta-analysis of each antioxidant. Pooled results from prospective cohort studies indicated that vitamin A, vitamin C, vitamin E, zinc, lutein, zeaxanthin, alpha carotene, beta carotene, beta cryptoxanthin, and lycopene have little or no effect in the primary prevention of early AMD. The three randomised clinical trials did not show that antioxidant supplements prevented early AMD.
Conclusions: There is insufficient evidence to support the role of dietary antioxidants, including the use of dietary antioxidant supplements, for the primary prevention of early AMD.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Primary prevention of age related macular degeneration.BMJ. 2007 Oct 13;335(7623):729. doi: 10.1136/bmj.39351.478924.BE. Epub 2007 Oct 8. BMJ. 2007. PMID: 17923719 Free PMC article.
References
-
- Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA 2004;291:1900-1. - PubMed
-
- Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290:2057-60. - PubMed
-
- Van Newkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000;107:1593-600. - PubMed
-
- Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains eye study. Ophthalmology 1995;102:1450-60. - PubMed
-
- Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous